We also found that the expression of DPYD, the limiting enzyme for pyrimidine nucleotide degradation,36 negatively correlated with the response to AVN-944 in KMT2Ar-AML (Supplementary Fig. 7c). This evidence concerns the gene DPYD and acute myeloid leukemia.